Reata Pharmaceuticals, Inc. to Report Second Quarter 2018 Financial Results and an Update on Development Programs on Wednesda...
August 06 2018 - 5:35PM
Reata Pharmaceuticals, Inc. (Nasdaq:RETA), a clinical-stage
biopharmaceutical company, today announced that the company will
host a conference call and live webcast on Wednesday, August 8,
2018, at 4:30 p.m. ET to report its second quarter 2018 financial
results and give an update on recent progress on its development
programs.
Second quarter financial results to be discussed
during the call will be included in an earnings press release that
will be available on the company’s website shortly before the call
at http://news.reatapharma.com and will be available for 12
months after the call. The webcast can be accessed on the
Investors & News section of the company’s website. The
conference call can be accessed by dialing (844) 348-3946
(toll-free domestic) or (213) 358-0892 (international) and using
conference ID 4089166. An archived replay of the webcast will
be available on the company’s website shortly after the event and
for 90 days after the call.
About Reata Pharmaceuticals,
Inc.
Reata is a clinical-stage biopharmaceutical
company that develops novel therapeutics for patients with serious
or life-threatening diseases by targeting molecular pathways
involved in the regulation of cellular metabolism and
inflammation. Reata’s two most advanced clinical candidates,
bardoxolone methyl and omaveloxolone, target the important
transcription factor Nrf2 that promotes the resolution of
inflammation by restoring mitochondrial function, reducing
oxidative stress, and inhibiting pro-inflammatory signaling.
Contact:Reata Pharmaceuticals, Inc.(972)
865-2219info@reatapharma.comhttp://news.reatapharma.com
Investor Relations:Vinny JindalVice President,
Strategy(469) 374-8721ir@reatapharma.com
Media:Matt Middleman, M.D.LifeSci Public
Relations(646)
627-8384matt.middleman@lifescipublicrelations.com
Reata Pharmaceuticals (NASDAQ:RETA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Reata Pharmaceuticals (NASDAQ:RETA)
Historical Stock Chart
From Apr 2023 to Apr 2024